ACD Labs Logo

Advancing AI Initiatives in R&D

Published online at Contract Pharma.

by Kristin Brooks

Richard Lee (Director of Core Technology at ACD/Labs) discusses the possibilities of using AI in R&D, and what this outlook means for IT leaders at pharmaceutical organizations.

Contract Pharma: What is the significance of human evaluation of data gathered by AI?

Richard Lee: AI is only as reliable as the data put into it, so being that a human is the facilitator of this, AI relies on human input. Similar to how an experienced team member reviews a less experienced peer's work, the same process between AI and human review should be in place. If the data is not well curated or validated, it runs the risk of being unusable. Only humans have knowledge from experience to ensure the best data is captured.

View the complete article online at Contract Pharma